Authorization

Moderna skyrockets 39% after its early trial for a coronavirus vaccine produced antibodies in all 45 patients (MRNA)

Moderna skyrockets 39% after its early trial for a coronavirus vaccine produced antibodies in all 45 patients (MRNA)
Moderna



Moderna announced on Monday that its early trial for its coronavirus vaccine produced antibodies in all patients.A 




Shares of the company surged 29% on Monday.A 




The company is aiming to have the vaccine ready for emergency use in the fall.




Watch Moderna trade live on Markets Insider.




Read more on Business Insider.A 




Moderna is soaring after an early trial of its coronavirus vaccine produced positive results, the company announced Monday.A 
Shares of the pharmaceutical company surged as much as 29% in premarket trading Monday in New York after it announced that all 45 volunteers in a trial for its coronavirus vaccine produced antibodies that may help protect them against the disease.A 
The phase 1 trial was conducted by the National Institute of Allergy and Infectious Diseases, which is part of the National Institutes of Health.
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Октябрь 2020    »
ПнВтСрЧтПтСбВс
 1234
567891011
12131415161718
19202122232425
262728293031